We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for December 19th
Read MoreHide Full Article
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 19th:
The Goldman Sachs Group, Inc. (GS - Free Report) : This investment banking, securities, and investment management company has a Zacks Rank #1 (Strong Buy) and seen the Zacks Consensus Estimate for its current year earnings rising 2% over the last 30 days.
Coherent, Inc. (COHR - Free Report) : This lasers and laser-based technology provider has a Zacks Rank #1 and seen the Zacks Consensus Estimate for its current year earnings jumping 11% over the last 30 days.
Pier 1 Imports, Inc. : This retailer has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings soaring 49.4% over the last 30 days.
Intra-Cellular Therapies, Inc. (ITCI - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings gaining 1.1% over the last 30 days.
Our trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Ranked Momentum Stocks to Buy for December 19th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 19th:
The Goldman Sachs Group, Inc. (GS - Free Report) : This investment banking, securities, and investment management company has a Zacks Rank #1 (Strong Buy) and seen the Zacks Consensus Estimate for its current year earnings rising 2% over the last 30 days.
GOLDMAN SACHS Price and Consensus
GOLDMAN SACHS Price and Consensus | GOLDMAN SACHS Quote
Goldman Sachs’ shares gained 14% over the past one month, compared with the S&P 500’s decline of 1.2%. The company possess a Momentum Score of A.
GOLDMAN SACHS Price
GOLDMAN SACHS Price | GOLDMAN SACHS Quote
Coherent, Inc. (COHR - Free Report) : This lasers and laser-based technology provider has a Zacks Rank #1 and seen the Zacks Consensus Estimate for its current year earnings jumping 11% over the last 30 days.
COHERENT INC Price and Consensus
COHERENT INC Price and Consensus | COHERENT INC Quote
Coherent’s shares gained 6.8% over the past one month. The company possesses a Momentum Score of B.
COHERENT INC Price
COHERENT INC Price | COHERENT INC Quote
Pier 1 Imports, Inc. : This retailer has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings soaring 49.4% over the last 30 days.
PIER 1 IMPORTS Price and Consensus
PIER 1 IMPORTS Price and Consensus | PIER 1 IMPORTS Quote
Pier 1 Imports’ shares rose about 50.7% over the past one month. The company possesses a Momentum Score of A.
PIER 1 IMPORTS Price
PIER 1 IMPORTS Price | PIER 1 IMPORTS Quote
Intra-Cellular Therapies, Inc. (ITCI - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings gaining 1.1% over the last 30 days.
INTRA-CELLULAR Price and Consensus
INTRA-CELLULAR Price and Consensus | INTRA-CELLULAR Quote
Intra-Cellular Therapies’ shares gained around 17.8% over the past one month. The company possesses a Momentum Score of B.
INTRA-CELLULAR Price
INTRA-CELLULAR Price | INTRA-CELLULAR Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here
Now See All Our Private Trades
Our trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>